Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Stratification of Vascular Profile in Multiple Myeloma Patients Using Thrombin Generation Test

Loula Papageorgiou, Patrick Van Dreden, PhD, Laurent Garderet, MD PhD, Matthieu Grusse, Ismail Elalamy, MD PhD, Grigoris Gerotziafas, MD PhD

Blood (2020) 136 (Supplement 1): 4.

https://doi.org/10.1182/blood-2020-139424

Published: 2020

Journal Articles

Differences in the Coagulation Profile in Women with Mild and Severe Preeclampsia

Elmina Lefkou, Patrick Van Dreden, PhD, Aurélie Rousseau, PhD, Grigorios T. Gerotziafas

Blood (2020) 136 (Supplement 1): 15–16.

https://doi.org/10.1182/blood-2020-137401

Published: 2020

Journal Articles

Profile of Thrombin Generation Assay and Thromboelastometry in Women with Moderate and Severe Preeclampsia. the Roadmap-Preeclampsia Study

Patrick Van Dreden, PhD, Elmina Lefkou, Aurélie Rousseau, PhD, Grigorios T. Gerotziafas

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-137384

Published: 2020

Journal Articles

Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study

Patrick Van Dreden, PhD, Guillaume Voiriot, Alexandre Alabbadi, Ismail Elalamy, MD PhD, Loula Papageorgiou, Hélène Cost, Aurélie Rousseau, PhD, Matthieu Turpin, Muriel Fartoukh, Grigorios T. Gerotziafas

Blood (2020) 136 (Supplement 1): 5–6.

https://doi.org/10.1182/blood-2020-140275

Published: 2020

Journal Articles

Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19

Grigoris Gerotziafas, MD PhD, Patrick Van Dreden, PhD, Loula Papageorgiou, Theodoros N Sergentanis, MD PhD, Meletios-Athanasios Dimopoulos, Ismail Elalamy, MD PhD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-136528

Published: 2020

Journal Articles

Hypercoagulability Biomarkers in a New Score Linked to Treatment Resistance for Multiple Myeloma Patients. the Roadmap-MM Study

Loula Papageorgiou, Despina Fotiou, BMBS, MA, Patrick Van Dreden, PhD, Laurent Garderet, MD PhD, Meletios A. Dimopoulos, MD, Ismail Elalamy, MD PhD, Mohamad Mohty, MD PhD, Grigoris Gerotziafas, MD PhD

Blood (2019) 134 (Supplement_1): 1913.

https://doi.org/10.1182/blood-2019-126954

Published: 2019

Journal Articles

Thrombophilia Screening in Adults Is Not Predictive of a Thrombotic Event after Bipulmonary Lung Transplantation

Patrick Van Dreden, PhD, Btissam Fatmi, Dominique Francois, Dominique Grenet, Clément Picard, Roseline Bironien, Francois Parquin, Antoine Roux, Marc Vasse, Professor

Blood (2019) 134 (Supplement_1): 2432.

https://doi.org/10.1182/blood-2019-127942

Published: 2019

Journal Articles

Procoagulant Microparticles Derived from Myeloma Plasma Cells Have a Determinant Role in the Hypercoagulable State Associated with Multiple Myeloma. a Modelization in Vitro Study

Loula Papageorgiou, Patrick Van Dreden, PhD, Meletios A. Dimopoulos, MD, Annette Larsen, Mohamad Mohty, MD PhD, Ismail Elalamy, MD PhD, Grigorios T. Gerotziafas

Blood (2019) 134 (Supplement_1): 2425.

https://doi.org/10.1182/blood-2019-124650

Published: 2019

Journal Articles

A Novel Plasma Panel for the Assessment of Chronic Liver Disease Severity

Clayton S Lewis, PhD, Marc Vasse, Professor, Patrick Van Dreden, PhD, Vladimir Y Bogdanov, PhD

Blood (2018) 132 (Supplement 1): 3784.

https://doi.org/10.1182/blood-2018-99-114906

Published: 2018

Journal Articles

The Detection of ANTI-Platelet Factor 4 /Heparin Antibodies during the Post Chirurgical Period of LUNG Transplantation Is Associated with a Higher Frequency of ACUTE Cellular Rejection

Francois Parquin, Antoine Roux, Patrick Van Dreden, PhD, Elisabeth Longchampt, Dominique Francois, Leila Zemoura, Paunet-Bodo Michéle, Roselyne Bironien, Marc Vasse, Professor

Blood (2018) 132 (Supplement 1): 2445.

https://doi.org/10.1182/blood-2018-99-114444

Published: 2018

Journal Articles

Transmission of Procoagulant Properties to Daughter Generations of Endothelial Cells upon Exposure to Cancer Cell-Derived Microparticles. a New Implication of Cancer Derived Microparticles in the Pathogenesis of Cancer Associated Thrombosis

Rania Amrane, Aurélie Rousseau, PhD, Annette Larsen, Patrick Van Dreden, PhD, Grigorios T. Gerotziafas

Blood (2018) 132 (Supplement 1): 1231.

https://doi.org/10.1182/blood-2018-99-114685

Published: 2018

Journal Articles

Chemoresistant Colorectal Cancer (CRC) Cells Show Increased Invasive Potential Which Is Part Is Mediated By VEGF-Signaling and Can be Attenuated By VEGF-Directed Agents

Thouroude Sandrine, Patrick Van Dreden, PhD, Grigorios T. Gerotziafas, Annette Larsen

Blood (2018) 132 (Supplement 1): 4974.

https://doi.org/10.1182/blood-2018-99-110202

Published: 2018

Journal Articles

In Newly Diagnosed Multiple Myeloma Patients, Longer Procoagulant Phospholipid-Dependent Clotting Time, Higher Levels of P-Selectin, D-Dimers and Thrombin Generation Peak Are Associated with Increased Risk of Resistance to Treatment: Results of the Prospective Roadmap-MM Study

Grigorios T. Gerotziafas, Despina Fotiou, BMBS, MA, Patrick Van Dreden, PhD, Theodoros N Sergentanis, Ismail Elalamy, MD PhD, Loula Papageorgiou, Matthieu Grusse, Stella Salta, Theodora Psaltopoulou, Annette Larsen, Evangelos Terpos, MD PhD, Meletios A Dimopoulos, MD

Blood (2018) 132 (Supplement 1): 2014.

https://doi.org/10.1182/blood-2018-99-114871

Published: 2018

Journal Articles

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer Associated Thrombosis. the Observational Roadmap-CAT Study

Grigorios T. Gerotziafas, MD PhD, Patrick Van Dreden, PhD, Stella Salta, Loula Papageorgiou, Paraskevi Boura, Annette Larsen, Jawed Fareed, PhD, Konstantinos Syrigos, Ismail Elalamy, MD PhD

Blood (2017) 130 (Supplement 1): 2381.

https://doi.org/10.1182/blood.V130.Suppl_1.2381.2381

Published: 2017

Journal Articles

An Ex Vivo Analysis of Thrombin Generation and Thromboelastometry in Patients Undergoing Treatment with Rivaroxaban Demonstrates Sustained Anticoagulant Effect and High Inter-Individual Variability

Stella Salta, Patrick Van Dreden, PhD, Loula Papageorgiou, Jawed Fareed, PhD, Ismail Elalamy, MD PhD, Grigorios T. Gerotziafas, MD PhD

Blood (2017) 130 (Supplement 1): 3722.

https://doi.org/10.1182/blood.V130.Suppl_1.3722.3722

Published: 2017

Journal Articles

Alteration of Endothelial Cell Hemostatic Equilibrium By Cancer Cell-Derived Microparticles, a New Insight in Pathogenesis of Cancer Associated Thrombosis

Aurélie Rousseau, PhD, Rania Amrane, Patrick Van Dreden, PhD, Loula Papageorgiou, Annette Larsen, Amir Khaterchi, Ismail Elalamy, MD PhD, Grigorios T. Gerotziafas, MD PhD

Blood (2017) 130 (Supplement 1): 3698.

https://doi.org/10.1182/blood.V130.Suppl_1.3698.3698

Published: 2017

Journal Articles

Defining the Balance between the Expression of Procoagulant, Anticoagulant and Angiogenic Molecules in Myeloma Plasma Cells

Loula Papageorgiou, Sandrine Thouronde, Patrick Van Dreden, PhD, Stella Salta, Laurent Garderet, MD PhD, Christelle Mazurier, Ismail Elalamy, MD PhD, Grigorios T. Gerotziafas, MD PhD

Blood (2017) 130 (Supplement 1): 5364.

https://doi.org/10.1182/blood.V130.Suppl_1.5364.5364

Published: 2017

Journal Articles

Procoagulant Phospholipid Dependent Clotting Time: A New Tool for the Identification of Multiple Myeloma Patients at Risk Poor Treatment Response

Fotiou Despina, Loula Papageorgiou, Stella Salta, Patrick Van Dreden, PhD, Evangelos Terpos, Jawed Fareed, PhD, Matthieu Grusse, Ismail Elalamy, MD PhD, Laurent Garderet, MD PhD, Christelle Mazurier, Grigorios T. Gerotziafas, MD PhD

Blood (2017) 130 (Supplement 1): 1110.

https://doi.org/10.1182/blood.V130.Suppl_1.1110.1110

Published: 2017

Journal Articles

Comparison of Ufh and Enoxaparin Originated from Bovine, Ovine and Porcine Mucosa with Functional Coagulation Assays

Grigorios T. Gerotziafas, MD PhD, Patrick Van Dreden, PhD, Walter Jeske, PhD, Jeanine M. Walenga, PhD, Debra Hoppensteadt, PhD, Annette Larsen, Ismail Elalamy, MD PhD, Yiming Yao, Jawed Fareed, PhD

Blood (2016) 128 (22): 5020.

https://doi.org/10.1182/blood.V128.22.5020.5020

Published: 2016

Journal Articles

Acquision of Resistance to Doxorubicin By Breast Cancer Cells MCF7 Enhances Their Procoagulant Properties and Alters the Efficacy of Antithrombotic Agents to Inhibit Thrombin Generation

Aurélie Rousseau, Patrick Van Dreden, PhD, Amir Khaterchi, Elisabeth Mbemba, Annette Larsen, Ismail Elalamy, MDPhD, Grigorios T. Gerotziafas, Dr

Blood (2015) 126 (23): 1113.

https://doi.org/10.1182/blood.V126.23.1113.1113

Published: 2015

NARROW

Stratification of Vascular Profile in Multiple Myeloma Patients Using Thrombin Generation Test

Differences in the Coagulation Profile in Women with Mild and Severe Preeclampsia

Profile of Thrombin Generation Assay and Thromboelastometry in Women with Moderate and Severe Preeclampsia. the Roadmap-Preeclampsia Study

Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study

Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19

Hypercoagulability Biomarkers in a New Score Linked to Treatment Resistance for Multiple Myeloma Patients. the Roadmap-MM Study

Thrombophilia Screening in Adults Is Not Predictive of a Thrombotic Event after Bipulmonary Lung Transplantation

Procoagulant Microparticles Derived from Myeloma Plasma Cells Have a Determinant Role in the Hypercoagulable State Associated with Multiple Myeloma. a Modelization in Vitro Study

A Novel Plasma Panel for the Assessment of Chronic Liver Disease Severity

The Detection of ANTI-Platelet Factor 4 /Heparin Antibodies during the Post Chirurgical Period of LUNG Transplantation Is Associated with a Higher Frequency of ACUTE Cellular Rejection

Transmission of Procoagulant Properties to Daughter Generations of Endothelial Cells upon Exposure to Cancer Cell-Derived Microparticles. a New Implication of Cancer Derived Microparticles in the Pathogenesis of Cancer Associated Thrombosis

Chemoresistant Colorectal Cancer (CRC) Cells Show Increased Invasive Potential Which Is Part Is Mediated By VEGF-Signaling and Can be Attenuated By VEGF-Directed Agents

In Newly Diagnosed Multiple Myeloma Patients, Longer Procoagulant Phospholipid-Dependent Clotting Time, Higher Levels of P-Selectin, D-Dimers and Thrombin Generation Peak Are Associated with Increased Risk of Resistance to Treatment: Results of the Prospective Roadmap-MM Study

Prospective Assessment of Clinical Risk Factors and Biomarkers of Hypercoagulability for the Identification of Patients with Lung Adenocarcinoma at Risk for Cancer Associated Thrombosis. the Observational Roadmap-CAT Study

An Ex Vivo Analysis of Thrombin Generation and Thromboelastometry in Patients Undergoing Treatment with Rivaroxaban Demonstrates Sustained Anticoagulant Effect and High Inter-Individual Variability

Alteration of Endothelial Cell Hemostatic Equilibrium By Cancer Cell-Derived Microparticles, a New Insight in Pathogenesis of Cancer Associated Thrombosis

Defining the Balance between the Expression of Procoagulant, Anticoagulant and Angiogenic Molecules in Myeloma Plasma Cells

Procoagulant Phospholipid Dependent Clotting Time: A New Tool for the Identification of Multiple Myeloma Patients at Risk Poor Treatment Response

Comparison of Ufh and Enoxaparin Originated from Bovine, Ovine and Porcine Mucosa with Functional Coagulation Assays

Acquision of Resistance to Doxorubicin By Breast Cancer Cells MCF7 Enhances Their Procoagulant Properties and Alters the Efficacy of Antithrombotic Agents to Inhibit Thrombin Generation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only